Arunjyoti Bio [ABVL] vs BLS International [BLS] Detailed Stock Comparison
Arunjyoti Bio
BSE
Loading...
BLS International
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Arunjyoti Bio wins in 7 metrics, BLS International wins in 11 metrics, with 0 ties. BLS International appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Arunjyoti Bio | BLS International | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 55.46 | 28.90 | BLS International |
| Price-to-Book Ratio | 3.30 | 9.44 | Arunjyoti Bio |
| Debt-to-Equity Ratio | 80.95 | 17.79 | BLS International |
| PEG Ratio | N/A | 59.22 | N/A |
| EV/EBITDA | 25.89 | 22.83 | BLS International |
| Profit Margin (TTM) | -4.34% | 23.43% | BLS International |
| Operating Margin (TTM) | 31.87% | 25.54% | Arunjyoti Bio |
| EBITDA Margin (TTM) | 31.87% | 25.54% | Arunjyoti Bio |
| Return on Equity | -5.63% | 25.17% | BLS International |
| Return on Assets (TTM) | -3.06% | 18.11% | BLS International |
| Free Cash Flow (TTM) | $-44.22M | $6.68B | BLS International |
| Dividend Yield | N/A | 0.14% | N/A |
| 1-Year Return | -18.26% | 1.76% | BLS International |
| Price-to-Sales Ratio (TTM) | 4.16 | 6.77 | Arunjyoti Bio |
| Enterprise Value | $1.36B | $160.91B | BLS International |
| EV/Revenue Ratio | 5.12 | 6.67 | Arunjyoti Bio |
| Gross Profit Margin (TTM) | 97.60% | 55.24% | Arunjyoti Bio |
| Revenue per Share (TTM) | $1 | $59 | BLS International |
| Earnings per Share (Diluted) | $-0.10 | $13.73 | BLS International |
| Beta (Stock Volatility) | -0.49 | -0.31 | Arunjyoti Bio |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Arunjyoti Bio vs BLS International Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Arunjyoti Bio | -3.55% | 4.42% | -1.83% | -29.81% | -61.77% | -69.30% |
| BLS International | -1.51% | 4.50% | 4.67% | 15.57% | -6.42% | -17.97% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Arunjyoti Bio | -18.26% | 50.38% | 629.63% | 107.37% | 168.64% | 212.70% |
| BLS International | 1.76% | 69.70% | 593.38% | 809.98% | 809.98% | 809.98% |
Performance & Financial Health Analysis: Arunjyoti Bio vs BLS International
| Metric | ABVL | BLS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.10B | ₹163.32B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 124,470 | 3,321,638 |
| 90 Day Avg. Volume | 85,964 | 2,302,079 |
| Last Close | ₹5.70 | ₹390.75 |
| 52 Week Range | ₹5.10 - ₹20.95 | ₹308.25 - ₹521.80 |
| % from 52W High | -72.80% | -25.11% |
| All-Time High | ₹30.07 (Jan 15, 2024) | ₹521.80 (Dec 30, 2024) |
| % from All-Time High | -81.04% | -25.11% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | 0.44% |
| Quarterly Earnings Growth | 0.40% | 0.50% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | 0.23% |
| Operating Margin (TTM) | 0.32% | 0.26% |
| Return on Equity (TTM) | -0.06% | 0.25% |
| Debt to Equity (MRQ) | 80.95 | 17.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.79 | ₹42.01 |
| Cash per Share (MRQ) | ₹0.03 | ₹21.94 |
| Operating Cash Flow (TTM) | ₹-12,115,000 | ₹6.13B |
| Levered Free Cash Flow (TTM) | ₹-18,215,000 | ₹5.08B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.14% |
| Last 12-Month Dividend | N/A | ₹0.50 |
Valuation & Enterprise Metrics Analysis: Arunjyoti Bio vs BLS International
| Metric | ABVL | BLS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 55.46 | 28.90 |
| Forward P/E | N/A | 59.22 |
| PEG Ratio | N/A | 59.22 |
| Price to Sales (TTM) | 4.16 | 6.77 |
| Price to Book (MRQ) | 3.30 | 9.44 |
| Market Capitalization | ||
| Market Capitalization | ₹1.10B | ₹163.32B |
| Enterprise Value | ₹1.36B | ₹160.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.12 | 6.67 |
| Enterprise to EBITDA | 25.89 | 22.83 |
| Risk & Other Metrics | ||
| Beta | -0.49 | -0.31 |
| Book Value per Share (MRQ) | ₹1.79 | ₹42.01 |
Financial Statements Comparison: Arunjyoti Bio vs BLS International
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ABVL | BLS |
|---|---|---|
| Revenue/Sales | ₹52.81M | ₹6.93B |
| Cost of Goods Sold | ₹1.27M | ₹3.42B |
| Gross Profit | ₹51.55M | ₹3.51B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-4.60M | ₹1.51B |
| EBITDA | ₹3.55M | ₹1.99B |
| Pre-Tax Income | ₹-10.42M | ₹1.67B |
| Income Tax | ₹9.48M | ₹214.34M |
| Net Income (Profit) | ₹-19.89M | ₹1.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ABVL | BLS |
|---|---|---|
| Cash & Equivalents | ₹5.92M | ₹2.83B |
| Total Current Assets | ₹147.98M | ₹11.42B |
| Total Current Liabilities | ₹52.90M | ₹4.89B |
| Long-Term Debt | ₹214.50M | ₹2.84B |
| Total Shareholders Equity | ₹323.79M | ₹20.19B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹433.29M | ₹3.21B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ABVL | BLS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ABVL | BLS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 124,470 | 3,321,638 |
| Average Daily Volume (90 Day) | 85,964 | 2,302,079 |
| Shares Outstanding | 186.38M | 411.57M |
| Float Shares | 11.91M | 116.07M |
| % Held by Insiders | 0.78% | 0.75% |
| % Held by Institutions | 0.00% | 0.04% |
Dividend Analysis & Yield Comparison: Arunjyoti Bio vs BLS International
| Metric | ABVL | BLS |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.50 |
| Last 12-Month Dividend Yield | N/A | 0.14% |
| 3-Year Avg Annual Dividend | N/A | ₹0.60 |
| 3-Year Avg Dividend Yield | N/A | 0.13% |
| 3-Year Total Dividends | N/A | ₹1.81 |
| Ex-Dividend Date | N/A | Sep 05, 2024 |